Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

ClinicalTrials.gov ID: NCT00063141

Public ClinicalTrials.gov record NCT00063141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 2:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma

Study identification

NCT ID
NCT00063141
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,302 participants

Conditions and interventions

Interventions

  • cetuximab Drug
  • Irinotecan Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2003
Primary completion
May 31, 2006
Completion
Sep 30, 2007
Last update posted
Apr 11, 2010

2003 – 2007

United States locations

U.S. sites
116
U.S. states
33
U.S. cities
107
Facility City State ZIP Site status
ImClone Investigational Site Tucson Arizona 85712
ImClone Investigational Site Pine Bluff Arkansas 71603
ImClone Investigational Site Bakersfield California 93309
ImClone Investigational Site Berkeley California 94704
ImClone Investigational Site Beverly Hills California 90211
ImClone Investigational Site Corona California 92708
ImClone Investigational Site Gilroy California 95020
ImClone Investigational Site Greenbrae California 95904
ImClone Investigational Site Long Beach California 90813
ImClone Investigational Site Los Angeles California 90033
ImClone Investigational Site Los Angeles California 90057
ImClone Investigational Site Montebello California 90640
ImClone Investigational Site Orange California 92868
ImClone Investigational Site Palm Springs California 92262
ImClone Investigational Site Rancho Mirage California 92270
ImClone Investigational Site San Diego California 92120
ImClone Investigational Site Stockton California 95204
ImClone Investigational Site Vallejo California 94589
ImClone Investigational Site Aurora Colorado 80012
ImClone Investigational Site Denver Colorado 80218
ImClone Investigational Site New Haven Connecticut 06520
ImClone Investigational Site New London Connecticut 06320
ImClone Investigational Site Norwich Connecticut 06360
ImClone Investigational Site Stamford Connecticut 06902
ImClone Investigational Site Fort Myers Florida 33901
ImClone Investigational Site Fort Myers Florida 33990
ImClone Investigational Site Inverness Florida 34452
ImClone Investigational Site Jacksonville Florida 32207
ImClone Investigational Site Jacksonville Florida 32209
ImClone Investigational Site Jacksonville Florida 32224
ImClone Investigational Site Lakeland Florida 33805
ImClone Investigational Site Miami Florida 33136
ImClone Investigational Site New Port Richey Florida 34652
ImClone Investigational Site Orlando Florida 32806
ImClone Investigational Site Port Saint Lucie Florida 34952
ImClone Investigational Site Atlanta Georgia 30309
ImClone Investigational Site Atlanta Georgia 30322
ImClone Investigational Site Columbus Georgia 31902-0951
ImClone Investigational Site Macon Georgia 31201
ImClone Investigational Site Savannah Georgia 31405
ImClone Investigational Site Tucker Georgia 30342
ImClone Investigational Site Honolulu Hawaii 96813
ImClone Investigational Site Naperville Illinois 60540
ImClone Investigational Site South Bend Indiana 46601
ImClone Investigational Site Kansas City Kansas 66160
ImClone Investigational Site Overland Park Kansas 66214
ImClone Investigational Site Lexington Kentucky 40536-0098
ImClone Investigational Site Louisville Kentucky 40202
ImClone Investigational Site Richmond Kentucky 40475
ImClone Investigational Site Baton Rouge Louisiana 70808
ImClone Investigational Site Lafayette Louisiana 70506
ImClone Investigational Site Metairie Louisiana 70006
ImClone Investigational Site Shreveport Louisiana 71103
ImClone Investigational Site Baltimore Maryland 21204
ImClone Investigational Site Frederick Maryland 21701
ImClone Investigational Site Boston Massachusetts 02135
ImClone Investigational Site Ann Arbor Michigan 48106
ImClone Investigational Site Detroit Michigan 48201
ImClone Investigational Site Southfield Michigan 48075
ImClone Investigational Site Minneapolis Minnesota 55407-3799
ImClone Investigational Site Robbinsdale Minnesota 55422
ImClone Investigational Site Saint Louis Park Minnesota 55426
ImClone Investigational Site Jackson Mississippi 39202
ImClone Investigational Site Kansas City Missouri 64111
ImClone Investigational Site Rolla Missouri 65401
ImClone Investigational Site St Louis Missouri 63110
ImClone Investigational Site Trenton New Jersey 08690
ImClone Investigational Site Voorhees Township New Jersey 08084
ImClone Investigational Site Albany New York 12208
ImClone Investigational Site East Setauket New York 11733
ImClone Investigational Site Latham New York 12110
ImClone Investigational Site Mineola New York 11501
ImClone Investigational Site New York New York 10016
ImClone Investigational Site Rexford New York 12148
ImClone Investigational Site Stony Brook New York 11794
ImClone Investigational Site The Bronx New York 10466
ImClone Investigational Site Valhalla New York 10595
ImClone Investigational Site Durham North Carolina 27710
ImClone Investigational Site Greenville North Carolina 27834
ImClone Investigational Site High Point North Carolina 27262
ImClone Investigational Site Raleigh North Carolina 27609
ImClone Investigational Site Winston-Salem North Carolina 27103
ImClone Investigational Site Winston-Salem North Carolina 27157
ImClone Investigational Site Bismarck North Dakota 58501
ImClone Investigational Site Cincinnati Ohio 45267
ImClone Investigational Site Cleveland Ohio 44106
ImClone Investigational Site Columbus Ohio 43235
ImClone Investigational Site Dayton Ohio 45459
ImClone Investigational Site Newark Ohio 43055
ImClone Investigational Site Oklahoma City Oklahoma 73118
ImClone Investigational Site Hershey Pennsylvania 17033
ImClone Investigational Site Philadelphia Pennsylvania 19106
ImClone Investigational Site Philadelphia Pennsylvania 19107
ImClone Investigational Site Philadelphia Pennsylvania 19141-3098
ImClone Investigational Site Pittsburgh Pennsylvania 15232
ImClone Investigational Site Greenville South Carolina 29615
ImClone Investigational Site Knoxville Tennessee 37916
ImClone Investigational Site Memphis Tennessee 38120
ImClone Investigational Site Nashville Tennessee 37203
ImClone Investigational Site Austin Texas 78759
ImClone Investigational Site Dallas Texas 75230
ImClone Investigational Site Houston Texas 77030
ImClone Investigational Site Plano Texas 75075
ImClone Investigational Site Temple Texas 76508
ImClone Investigational Site Ogden Utah 84403
ImClone Investigational Site Arlington Virginia 22205
ImClone Investigational Site Danville Virginia 24541
ImClone Investigational Site Newport News Virginia 23606
ImClone Investigational Site Richmond Virginia 23230
ImClone Investigational Site Seattle Washington 98104
ImClone Investigational Site Spokane Washington 99204
ImClone Investigational Site Spokane Washington 99218
ImClone Investigational Site Walla Walla Washington 99362
ImClone Investigational Site Green Bay Wisconsin 54301
ImClone Investigational Site Madison Wisconsin 53792
ImClone Investigational Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00063141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2010 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00063141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →